The Effects of a High-Protein Diet on Markers of Muscle Damage Following Exercise in Active Older Adults: A Randomized, Controlled Trial.


Journal

International journal of sport nutrition and exercise metabolism
ISSN: 1543-2742
Titre abrégé: Int J Sport Nutr Exerc Metab
Pays: United States
ID NLM: 100939812

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 29 04 2020
revised: 02 06 2020
accepted: 10 06 2020
pubmed: 23 7 2020
medline: 1 7 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

This study examined whether a higher protein diet following strenuous exercise can alter markers of muscle damage and inflammation in older adults. Using a double-blind, independent group design, 10 males and eight females (age 57 ± 4 years; mass 72.3 ± 5.6 kg; height 1.7 ± 6.5 m) were supplied with a higher protein (2.50 g·kg-1·day-1) or moderate protein (1.25 g·kg-1·day-1) diet for 48 hr after 140 squats with 25% of their body mass. Maximal isometric voluntary contractions, muscle soreness, creatine kinase, Brief Assessment of Mood Adapted, and inflammatory markers were measured preexercise, and 24 hr and 48 hr postexercise. The maximal isometric voluntary contractions decreased postexercise (p = .001, ηp2=.421), but did not differ between groups (p = .822, ηp2=.012). Muscle soreness peaked at 24 hr post in moderate protein (44 ± 30 mm) and 48 hr post in higher protein (70 ± 46 mm; p = .005; ηp2=.282); however, no group differences were found (p = .585; ηp2=.083). Monocytes and lymphocytes significantly decreased postexercise, and eosinophils increased 24 hr postexercise (p < 0.05), but neutrophils, creatine kinase, interleukin-6, C-reactive protein, monocyte chemotactic protein-1, and Brief Assessment of Mood Adapted were unchanged by exercise or the intervention (p > .05). In conclusion, 2.50 g·kg-1·day-1 of protein is not more effective than 1.25 g·kg-1·day-1 for attenuating indirect markers of muscle damage and inflammation following strenuous exercise in older adults.

Identifiants

pubmed: 32698121
doi: 10.1123/ijsnem.2020-0113
pii: ijsnem.2020-0113
doi:
pii:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-329

Subventions

Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom

Auteurs

Tom Clifford (T)

Newcastle University.
Loughborough University.

Eleanor J Hayes (EJ)

Newcastle University.

Jadine H Scragg (JH)

Newcastle University.

Guy Taylor (G)

Newcastle University.

Kieran Smith (K)

Newcastle University.

Kelly A Bowden Davies (KA)

Newcastle University.

Emma J Stevenson (EJ)

Newcastle University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH